Legend Biotech Corp
NASDAQ:LEGN

Watchlist Manager
Legend Biotech Corp Logo
Legend Biotech Corp
NASDAQ:LEGN
Watchlist
Price: 24.7 USD -5.44%
Market Cap: 4.5B USD

Relative Value

The Relative Value of one LEGN stock under the Base Case scenario is hidden USD. Compared to the current market price of 24.7 USD, Legend Biotech Corp is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LEGN Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
42
Median 3Y
23.2
Median 5Y
68.2
Industry
7.9
Forward
4.3
vs History
vs Industry
Median 3Y
-24.8
Median 5Y
-22.5
Industry
24
Forward
-25.9
vs History
vs Industry
Median 3Y
-35.3
Median 5Y
-34.9
Industry
21.6
vs History
vs Industry
Median 3Y
-34
Median 5Y
-33.1
Industry
23.7
vs History
98
vs Industry
15
Median 3Y
8.2
Median 5Y
9.2
Industry
3.4
vs History
98
vs Industry
38
Median 3Y
20.7
Median 5Y
61.9
Industry
8.3
Forward
3.6
vs History
66
vs Industry
31
Median 3Y
27.2
Median 5Y
14.4
Industry
10.3
vs History
vs Industry
Median 3Y
-23.9
Median 5Y
-21.8
Industry
6.7
Forward
-26.9
vs History
vs Industry
Median 3Y
-22
Median 5Y
-20.9
Industry
7.2
Forward
-24.1
vs History
vs Industry
Median 3Y
-31.9
Median 5Y
-31.3
Industry
8.2
vs History
vs Industry
Median 3Y
-31.5
Median 5Y
-30.7
Industry
6.7
vs History
96
vs Industry
14
Median 3Y
19.6
Median 5Y
45.7
Industry
5.7

Multiples Across Competitors

LEGN Competitors Multiples
Legend Biotech Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Legend Biotech Corp
NASDAQ:LEGN
4.5B USD 5 -18.9 -22.7 -19.9
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 067 817 -161 919.3 -196 621.7 -194 378
US
Abbvie Inc
NYSE:ABBV
393.8B USD 6.6 167.8 16.3 23.1
US
Amgen Inc
NASDAQ:AMGN
170.5B USD 4.7 24.4 17.7 17.7
US
Gilead Sciences Inc
NASDAQ:GILD
148B USD 5.1 18.3 12.2 12.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
111.8B USD 9.5 30.4 22.3 23.3
US
Epizyme Inc
F:EPE
94.1B EUR 2 067.9 -527.7 -574.6 -559.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
73.4B USD 5.2 16 15.2 17.2
AU
CSL Ltd
ASX:CSL
88B AUD 3.7 19.4 13.1 16.3
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
55.5B USD 17.2 1 274.9 167.8 203.5
NL
argenx SE
XBRU:ARGX
47B EUR 15.2 35.7 61.8 63.5
P/E Multiple
Earnings Growth PEG
US
Legend Biotech Corp
NASDAQ:LEGN
Average P/E: 198.4
Negative Multiple: -18.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -161 919.3 N/A N/A
US
Abbvie Inc
NYSE:ABBV
167.8
89%
1.9
US
Amgen Inc
NASDAQ:AMGN
24.4
45%
0.5
US
Gilead Sciences Inc
NASDAQ:GILD
18.3
190%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
30.4
N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -527.7 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16
9%
1.8
AU
CSL Ltd
ASX:CSL
19.4
11%
1.8
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
1 274.9
N/A N/A
NL
argenx SE
XBRU:ARGX
35.7
40%
0.9
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Legend Biotech Corp
NASDAQ:LEGN
Average EV/EBITDA: 40.8
Negative Multiple: -22.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -196 621.7 N/A N/A
US
Abbvie Inc
NYSE:ABBV
16.3
14%
1.2
US
Amgen Inc
NASDAQ:AMGN
17.7
11%
1.6
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
7%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
22.3
16%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -574.6 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.2
11%
1.4
AU
CSL Ltd
ASX:CSL
13.1
8%
1.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
167.8
N/A N/A
NL
argenx SE
XBRU:ARGX
61.8
807%
0.1
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Legend Biotech Corp
NASDAQ:LEGN
Average EV/EBIT: 47.1
Negative Multiple: -19.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 378 N/A N/A
US
Abbvie Inc
NYSE:ABBV
23.1
30%
0.8
US
Amgen Inc
NASDAQ:AMGN
17.7
20%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
12.2
12%
1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
23.3
16%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -559.3 N/A N/A
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.2
13%
1.3
AU
CSL Ltd
ASX:CSL
16.3
11%
1.5
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
203.5
N/A N/A
NL
argenx SE
XBRU:ARGX
63.5
N/A N/A